Skip to content
BMS VIP Forum Application
1:1 Sessions will be held with representatives from BMS on February 14th. LSWI will reach out to you by January 9th if you are selected for a meeting.
*
1.
First Name
(Required.)
*
2.
Last Name
(Required.)
*
3.
Professional Title
(Required.)
*
4.
Phone
(Required.)
*
5.
Email Address
(Required.)
*
6.
Company name
(Required.)
*
7.
Street address
(Required.)
*
8.
City
(Required.)
*
9.
State
(Required.)
*
10.
Website
(Required.)
11.
Year incorporation/ formation
12.
Number of employees
*
13.
Subsector (select one)
(Required.)
Biotech
Medtech
Digital Health/Health IT
Global Health
Research Institute
None of the above
Other (please specify)
*
14.
Technology Classification (select all that apply)
(Required.)
Medical Device
Diagnostic
Platform Technology
Therapeutic
Software
Other (please specify)
*
15.
Area of focus (select all that apply)
(Required.)
Immuno-Oncology
Manufacturing, Cell and Gene Technologies
Cell Therapy
Solid Tumor Oncology
Platform Technologies (no devices or diagnostics)
Other (please specify)
16.
Management team and Board (200 word max)
*
17.
Target / Underlying Biology / MOA / Modality
(Required.)
*
18.
Disease area(s) / Disease(s) targeted
(Required.)
*
19.
Description of your technology (200 word max)
(Required.)
*
20.
Development Stage
(Required.)
Pre-Clinical
IND
Phase I
Phase II
Phase III
Approved
NDA
*
21.
Key partnership objectives (200 word max)
(Required.)
*
22.
Current partnerships and/or alliances (200 word max)
(Required.)
*
23.
Key next steps in development
(Required.)
24.
Are you generating revenue?
Yes
No
*
25.
Recent milestones and next steps (200 word max)
(Required.)
*
26.
Status of Intellectual Property
(Required.)
License pending
License executed
Provisional patent filed
Patent pending
Patent issued
PCT application filed
Other (please specify)
*
27.
Ownership
(Required.)
*
28.
Capital raised to date and funding history
(Required.)
